Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Olema Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 157
- +29 vs. Q3 2024
- Shares held
- 71.3M
- +13.2M (+22.8%) vs. Q3 2024
- Total value
- $415.4M
- −$277.9M (−40.1%) vs. Q3 2024
- New holders
- 38
- 53 more added
- Sold out
- 9
- 39 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OLMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $1.28B |
| Q1 2026 | 195 | $1.51B |
| Q4 2025 | 200 | $2.27B |
| Q3 2025 | 126 | $668.2M |
| Q2 2025 | 123 | $300.5M |
| Q1 2025 | 134 | $248.0M |
| Q4 2024 | 157 | $415.4M |
| Q3 2024 | 130 | $700.3M |
| Q2 2024 | 129 | $626.9M |
| Q1 2024 | 126 | $635.2M |
| Q4 2023 | 113 | $717.1M |
| Q3 2023 | 97 | $584.4M |
| Q2 2023 | 87 | $329.2M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 67 | $81.6M |
| Q3 2022 | 73 | $92.1M |
| Q2 2022 | 76 | $139.2M |
| Q1 2022 | 91 | $155.2M |
| Q4 2021 | 97 | $359.5M |
| Q3 2021 | 76 | $1.01B |
| Q2 2021 | 69 | $1.05B |
| Q1 2021 | 74 | $1.16B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Olema Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 74,919 | $436.8K | 0.00% | 00.0% | Unchanged |
| Rafferty Asset Management, LLC | 81,424 | $474.7K | 0.00% | −9,051−10.0% | Reduced |
| HighTower Advisors, LLC | 87,476 | $510.0K | 0.00% | +87,476 | New |
| Two Sigma Advisers, LP | 89,000 | $518.9K | 0.00% | −12,200−12.1% | Reduced |
| ExodusPoint Capital Management, LP | 91,298 | $532.0K | 0.01% | +21,457+30.7% | Added |
| Ikarian Capital, LLC | 91,994 | $536.3K | 0.15% | −60.0% | Reduced |
| Dana Investment Advisors, Inc. | 92,039 | $536.6K | 0.02% | +6,232+7.3% | Added |
| Victory Capital Management Inc | 93,100 | $542.8K | 0.00% | −758,412−89.1% | Reduced |
| UBS Asset Management Americas Inc | 93,979 | $547.9K | 0.00% | +18,005+23.7% | Added |
| Barclays PLC | 114,879 | $669.7K | 0.00% | +19,964+21.0% | Added |
| Nuveen Asset Management, LLC | 118,434 | $690.5K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 128,666 | $750.1K | 0.00% | −3,516−2.7% | Reduced |
| Newtyn Management, LLC | 140,000 | $816.2K | 0.14% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 157,300 | $917.1K | 0.00% | +127,900+435.0% | Added |
| JPMorgan Chase & Co | 160,751 | $937.2K | 0.00% | −20,281−11.2% | Reduced |
| Marshall Wace, LLP | 192,943 | $1.12M | 0.00% | −47,444−19.7% | Reduced |
| BNP Paribas Arbitrage, SA | 193,748 | $1.13M | 0.00% | +193,748 | New |
| HighVista Strategies LLC | 212,185 | $1.24M | 0.46% | 00.0% | Unchanged |
| Hennion & Walsh Asset Management, Inc. | 212,246 | $1.24M | 0.06% | +94,651+80.5% | Added |
| Driehaus Capital Management LLC | 220,264 | $1.28M | 0.01% | +220,264 | New |
| Silverarc Capital Management, LLC | 233,281 | $1.36M | 0.30% | −221,801−48.7% | Reduced |
| Pier Capital, LLC | 272,372 | $1.59M | 0.23% | +272,372 | New |
| Franklin Resources Inc | 273,706 | $1.60M | 0.00% | +258,625+1,714.9% | Added |
| Alliancebernstein L.P. | 313,982 | $1.83M | 0.00% | +137,319+77.7% | Added |
| Charles Schwab Investment Management Inc | 332,950 | $1.94M | 0.00% | +2,189+0.7% | Added |
| Adage Capital Partners GP, L.L.C. | 365,198 | $2.13M | 0.00% | −34,802−8.7% | Reduced |
| Goldman Sachs Group Inc | 382,917 | $2.23M | 0.00% | −79,430−17.2% | Reduced |
| Northern Trust Corp | 423,787 | $2.47M | 0.00% | +34,053+8.7% | Added |
| Ameriprise Financial Inc | 449,698 | $2.62M | 0.00% | −13,426−2.9% | Reduced |
| Schonfeld Strategic Advisors LLC | 505,400 | $2.95M | 0.02% | +43,474+9.4% | Added |
| Schroder Investment Management Group | 533,111 | $2.99M | 0.00% | +450,924+548.7% | Added |
| UBS Group AG | 560,506 | $3.27M | 0.00% | +482,959+622.8% | Added |
| Boxer Capital Management, LLC | 650,000 | $3.79M | 0.32% | +650,000 | New |
| Bank of America Corp | 865,339 | $5.04M | 0.00% | +454,400+110.6% | Added |
| Geode Capital Management, LLC | 926,162 | $5.40M | 0.00% | −8,767−0.9% | Reduced |
| Millennium Management LLC | 979,219 | $5.71M | 0.00% | +901,159+1,154.4% | Added |
| Morgan Stanley | 1,024,477 | $5.97M | 0.00% | +774,876+310.4% | Added |
| Balyasny Asset Management LLC | 1,127,589 | $6.57M | 0.02% | +418,492+59.0% | Added |
| Dimensional Fund Advisors LP | 1,332,792 | $7.77M | 0.00% | −44,132−3.2% | Reduced |
| Woodline Partners LP | 1,357,479 | $7.91M | 0.05% | +3,293+0.2% | Added |
| Vivo Capital, LLC | 1,505,862 | $8.78M | 0.98% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,525,484 | $8.84M | 0.00% | +522,799+52.1% | Added |
| Candriam Luxembourg S.C.A. | 1,551,562 | $9.05M | 0.05% | +44,798+3.0% | Added |
| Avoro Capital Advisors LLC | 1,651,982 | $9.63M | 0.14% | +1,651,982 | New |
| Citadel Advisors LLC | 1,683,207 | $9.81M | 0.01% | +430,462+34.4% | Added |
| State Street Corp | 1,857,527 | $10.8M | 0.00% | −112,436−5.7% | Reduced |
| Pictet Asset Management Holding SA | 1,883,354 | $11.0M | 0.01% | +215,895+12.9% | Added |
| Lightspeed Management Company, L.L.C. | 1,930,894 | $11.3M | 3.97% | +1,930,894 | New |
| Vanguard Group Inc | 2,685,009 | $15.7M | 0.00% | +152,117+6.0% | Added |
| MPM Oncology Impact Management LP | 2,912,550 | $17.0M | 2.41% | +231,954+8.7% | Added |
| Logos Global Management LP | 3,208,875 | $18.7M | 2.19% | 00.0% | Unchanged |
| Deep Track Capital, LP | 3,442,833 | $20.1M | 0.75% | −557,167−13.9% | Reduced |
| Point72 Asset Management, L.P. | 3,670,826 | $21.4M | 0.06% | −16,548−0.4% | Reduced |
| BlackRock, Inc. | 3,789,832 | $22.1M | 0.00% | −57,639−1.5% | Reduced |
| BVF Inc | 5,715,893 | $33.3M | 1.13% | −3,420,000−37.4% | Reduced |
| Paradigm Biocapital Advisors LP | 7,304,970 | $42.6M | 1.48% | +1,801,370+32.7% | Added |
| Bain Capital Life Sciences Investors, LLC | 7,470,214 | $43.6M | 5.12% | +7,470,214 | New |
| Great Point Partners LLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −650,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −120,093−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −103,500−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −63,041−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −33,296−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −19,894−100.0% | Sold out |
| Fortitude Family Office, LLC | 0 | $0 | 0.00% | −319−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Ghost Tree Capital, LLC | – | – | – | – | Not filed |
| ClariVest Asset Management LLC | – | – | – | – | Not filed |